{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:56:53Z","timestamp":1781002613164,"version":"3.54.1"},"reference-count":32,"publisher":"Georg Thieme Verlag KG","issue":"S 01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Perinatol"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:p>\n            Objective\u2003To evaluate the feasibility and impact of using the first-trimester ultrasound visit to identify and counsel women at increased risk of preeclampsia about the benefits of low-dose aspirin (LDA) for preventing preeclampsia. We also assessed patient-reported utilization of LDA, perceived risk for preeclampsia, and clinical outcomes.<\/jats:p><jats:p>\n            Study Design\u2003Women presenting for routine first-trimester nuchal-translucency (NT) ultrasounds were screened for clinical preeclampsia risks using a self-administered risk assessment. Women at moderate or high risk for preeclampsia were counseled to take LDA, if not already taking it. LDA utilization and perceived risk for preeclampsia were assessed during the second-trimester ultrasound. Factors associated with LDA utilization were analyzed. Pregnancy outcomes were compared between those who used LDA and those who did not.<\/jats:p><jats:p>\n            Results\u2003Slightly more than 20% of patients (765\/3,669) screened at increased risk for developing preeclampsia. Of those, 67.8% (519\/765) had not received LDA recommendations from their referring obstetrician and 97 had not been taking LDA despite being advised to do so. Combined, 94.6% (583\/616) of these patients eligible to start LDA prophylaxis received the indicated counseling during the ultrasound visit. A total of 61.4% (358\/583) of women completed the follow-up form and of those 77.9% (279\/358) reported taking LDA. Screening at increased risk for preeclampsia and perception of increased risk were positively associated with LDA utilization, whereas concerns for LDA safety were negatively associated with use. African American\/Black patients and Medicaid recipients were less likely to use LDA. Pregnancy outcomes were similar between those who used LDA and those who did not.<\/jats:p><jats:p>\n            Conclusion\u2003Assessing preeclampsia risk and counseling patients about LDA at the time of the NT ultrasound are feasible in the ultrasound unit and led to good LDA utilization among women at increased risk for preeclampsia. This intervention may standardize patient care and help close the disparity in maternal health.<\/jats:p><jats:p>\n            Key Points\n          <\/jats:p>","DOI":"10.1055\/s-0043-1777445","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T23:57:56Z","timestamp":1702684676000},"page":"e3187-e3195","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S","title":["Feasibility of Universal Screening for Preeclampsia Risk and Aspirin Recommendation in the Ultrasound Unit"],"prefix":"10.1055","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8365-0620","authenticated-orcid":false,"given":"Ver\u00f3nica Maria","family":"Pimentel","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Saint Francis Hospital and Medical Center, Hartford Connecticut"},{"name":"Department of Obstetrics and Gynecology, Frank H. Netter School of Medicine, Quinnipiac University, North Haven, Connecticut"},{"name":"Department of Obstetrics and Gynecology, University of Connecticut School of Medicine, Farmington, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander D. Almeida","family":"Larrea","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Saint Francis Hospital and Medical Center, Hartford Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie J.","family":"Renaud","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Frank H. Netter School of Medicine, Quinnipiac University, North Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Sloan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Saint Francis Hospital and Medical Center, Hartford Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1134-9967","authenticated-orcid":false,"given":"Reinaldo","family":"Figueroa","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Saint Francis Hospital and Medical Center, Hartford Connecticut"},{"name":"Department of Obstetrics and Gynecology, Frank H. Netter School of Medicine, Quinnipiac University, North Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Wakefield","sequence":"additional","affiliation":[{"name":"Department of Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Crowell","sequence":"additional","affiliation":[{"name":"Department of Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","author":"American College of Obstetricians and Gynecologists","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jama.2021.8551","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"326","author":"J T Henderson","year":"2021","journal-title":"JAMA"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/AOG.0000000000002709","article-title":"Low-dose aspirin use during pregnancy. ACOG committee opinion no. 743","volume":"132","author":"American College of Obstetricians and Gynecologists","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force recommendation statement","volume":"326","author":"K W Davidson","year":"2021","journal-title":"JAMA"},{"issue":"9575","key":"ref5","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"L M Askie","year":"2007","journal-title":"Lancet"},{"issue":"8898","key":"ref6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women","volume":"343","author":"CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group","year":"1994","journal-title":"Lancet"},{"issue":"03","key":"ref7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"S Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.preghy.2018.08.244","article-title":"A cohort study utilising a biochemical assessment of aspirin compliance vs resistance in high-risk pregnant women","volume":"13","author":"R Shanmugalingam","year":"2018","journal-title":"Pregnancy Hypertens"},{"issue":"06","key":"ref9","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/AOG.0000000000001115","article-title":"A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States","volume":"126","author":"E F Werner","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"06","key":"ref10","doi-asserted-by":"crossref","first-page":"685.e1","DOI":"10.1016\/j.ajog.2017.08.110","article-title":"Aspirin for evidence-based preeclampsia prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia","volume":"217","author":"D Wright","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"07","key":"ref11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/jch.12541","article-title":"Low-dose aspirin for preventing preeclampsia and its complications: a meta-analysis","volume":"17","author":"T T Xu","year":"2015","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"E Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"07","key":"ref13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"D L Rolnik","year":"2017","journal-title":"N Engl J Med"},{"issue":"07","key":"ref14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/aogs.13808","article-title":"Low-dose-aspirin usage among women with an increased preeclampsia risk: a prospective cohort study","volume":"99","author":"P van Montfort","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"05","key":"ref15","doi-asserted-by":"crossref","first-page":"100663","DOI":"10.1016\/j.ajogmf.2022.100663","article-title":"Assessment of adherence to aspirin for preeclampsia prophylaxis and reasons for nonadherence","volume":"4","author":"D N Olson","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"e2130960","DOI":"10.1001\/jamanetworkopen.2021.30960","article-title":"Miscommunication about low-dose aspirin for preeclampsia prevention-further support for universal prophylaxis","volume":"4","author":"A K Lewkowitz","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"e2130804","DOI":"10.1001\/jamanetworkopen.2021.30804","article-title":"Use of a smartphone app to explore potential underuse of prophylactic aspirin for preeclampsia","volume":"4","author":"T Krishnamurti","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-0040-1718580","article-title":"Improving utilization of aspirin for prevention of preeclampsia in a high-risk urban cohort: a prospective cohort study","volume":"38","author":"R C Boelig","year":"2021","journal-title":"Am J Perinatol"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"M L LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"issue":"06","key":"ref20","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1097\/AOG.0000000000003892","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin summary, number 222","volume":"135","author":"Gestational Hypertension and Preeclampsia","year":"2020","journal-title":"Obstet Gynecol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.copsyc.2015.03.012","article-title":"Risk perceptions and health behavior","volume":"5","author":"R Ferrer","year":"2015","journal-title":"Curr Opin Psychol"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1177\/0146167209343124","article-title":"The dark side of optimism: unrealistic optimism about problems with alcohol predicts subsequent negative event experiences","volume":"35","author":"A J Dillard","year":"2009","journal-title":"Pers Soc Psychol Bull"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"e2142343","DOI":"10.1001\/jamanetworkopen.2021.42343","article-title":"Estimated prevalence of risk factors for preeclampsia among individuals giving birth in the US in 2019","volume":"5","author":"S M Wheeler","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"09","key":"ref24","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.2337\/dc07-0618","article-title":"Risk perception for diabetes among women with histories of gestational diabetes mellitus","volume":"30","author":"C Kim","year":"2007","journal-title":"Diabetes Care"},{"issue":"24","key":"ref25","first-page":"1","article-title":"Women's barriers to weight loss, perception of future diabetes risk and opinions of diet strategies following gestational diabetes: an online survey","volume":"17","author":"K L Gray","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"M K Hoffman","year":"2020","journal-title":"Lancet"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/1471-0528.16361","article-title":"Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study","volume":"128","author":"G P Guy","year":"2021","journal-title":"BJOG"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"e2139564","DOI":"10.1001\/jamanetworkopen.2021.39564","article-title":"Nativity-related disparities in preeclampsia and cardiovascular disease risk among a racially diverse cohort of US women","volume":"4","author":"E Boakye","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"L C Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"issue":"03","key":"ref34","doi-asserted-by":"crossref","first-page":"B7","DOI":"10.1016\/j.ajog.2020.06.003","article-title":"Society for Maternal-Fetal Medicine Special Statement: checklists for preeclampsia risk-factor screening to guide recommendations for prophylactic low-dose aspirin","volume":"223","author":"C A Combs","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2147\/IJWH.S283239","article-title":"Reviewing accuracy of first trimester screening for preeclampsia using maternal factors and biomarkers","volume":"14","author":"S L Malone","year":"2022","journal-title":"Int J Womens Health"},{"issue":"06","key":"ref36","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"N O'Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["American Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1777445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:48:09Z","timestamp":1730814489000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1777445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":32,"journal-issue":{"issue":"S 01","published-online":{"date-parts":[[2024,5,13]]},"published-print":{"date-parts":[[2024,5]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1777445","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0735-1631","1098-8785"],"issn-type":[{"value":"0735-1631","type":"print"},{"value":"1098-8785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]}}}